Alloy Therapeutics Inc

## Alloy Therapeutics Inc. Alloy Therapeutics Inc. is a privately held biotechnology company headquartered in Lexington, Massachusetts. The company employs 150 people and generates approximately $50 million in annual revenue. Alloy Therapeutics provides a range of services and platforms to the global scientific community, empowering them to develop better medicines. Their offerings include access to a growing stable of antibody and bispecific discovery platforms that combine in vivo and in vitro wet-lab capabilities with AI/ML. They also offer a fully integrated Keyway™ TCR discovery service, enabling the exploration of therapeutic potential through T cell receptor (TCR) modalities. Alloy Therapeutics differentiates itself through its innovative technologies and collaborative approach. Their AntiClastic™ ASO format enhances the potency of nucleic acid-based therapeutics while minimizing off-target interactions and inflammatory responses. They also offer co-building opportunities for new biotechnology companies through their affiliated Venture Studio, 82VS. For more information about Alloy Therapeutics and their services, please visit their website at www.alloytx.com/.